Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvin Ng

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trialRaghav Sundar, Alvin Ng, Hermioni Zouridis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 29, 2013
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Bo Abrahamsen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 16, 2010
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Peter R Ebeling, et al.
Cancer Discovery|March 22, 2017
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaAditi Qamra, Manjie Xing, Nisha Padmanabhan, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trialRaghav Sundar, Alvin Ng, Hermioni Zouridis, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 29, 2013
Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Bo Abrahamsen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 16, 2010
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral ResearchElizabeth Shane, David Burr, Peter R Ebeling, et al.
Cancer Discovery|March 22, 2017
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaAditi Qamra, Manjie Xing, Nisha Padmanabhan, et al.
Pageof 4